80jili login
ATLANTA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended October 31, 2024 on Monday December 16, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, December 17, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register . You can also join by phone by dialing 877-407-8291. A replay of the conference call will be available from Tuesday December 17, 2024, at 12:00 PM ET to Thursday December 24, 2024, at 12:00 PM ET by dialing 877-660-6853 or 201-612-7415 with conference ID 13750374. An online replay of the presentation will also be available for six months following the presentation in the Investor Relations section of the Streamline website, www.streamlinehealth.net . About Streamline Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net . Source: Streamline Health Solutions, Inc. Company Contact Jacob Goldberger Vice President, Finance 303-887-9625 jacob.goldberger@streamlinehealth.netDonald Trump asked the Supreme Court to pause a law that would ban TikTok. The president-elect filed a brief urging SCOTUS to give him time to pursue a political resolution. Congress passed a law that requires TikTok's Chinese owners to divest or be banned from US app stores. President-elect Donald Trump asked the Supreme Court to pause the law that would ban TikTok in mid-January until after his inauguration. Trump filed a brief on Friday urging the top court to give him time to "pursue a political resolution" before agreeing to ban the social media app. In April, Congress passed a bipartisan law that established a nine-month deadline for TikTok's Chinese parent company to divest from the app or be barred from US app stores. Neither TikTok nor Trump's lawyers immediately responded to Business Insider's request for comment. BI also reached out to the Supreme Court. In the Friday filing, Trump's lawyers highlighted the president-elect's "consummate deal-making expertise," suggesting Trump has the "political will" to negotiate a resolution that would simultaneously "save the platform" and address the national security concerns highlighted in the Congressional bill. The nine-month deadline is officially up on January 19, which is one day before Trump assumes office for a second time. Trump previously supported a TikTok ban but appeared to change his mind in recent months. He met with the app's CEO earlier this month and said he had a "warm spot" in his heart for TikTok. Legal experts previously told BI that Trump has a couple of options to try to keep the app running in the US, including asking his Department of Justice to ignore the divest law or trying to rework strategic interpretations of the law. Trump and his lawyers also argue that the president-elect has a mandate from American voters to protect their free-speech rights, including those who use TikTok. "Moreover, President Trump is one of the most powerful, prolific, and influential users of social media in history," the file said." "Consistent with his commanding presence in this area, President Trump currently has 14.7 million followers on TikTok with whom he actively communicates, allowing him to evaluate TikTok's importance as a unique medium for freedom of expression, including core political speech," lawyers added.
General Motors (GM) announced on Dec. 10 its decision to exit the robotaxi market after investing more than $10 billion in its Cruise autonomous vehicle unit. GM said it will no longer fund Cruise development efforts due to “the considerable time and resources that would be needed to scale the business, along with an increasingly competitive robotaxi market.” The company said it will combine Cruise’s technical team with its own to advance autonomous and assisted driving. The automaker noted that it expects the restructuring will reduce its annual spending by more than $1 billion starting in the first half of 2025. “GM is committed to delivering the best driving experiences to our customers in a disciplined and capital efficient manner,” GM CEO Mary Barra said in a statement. GM acquired a controlling stake in Cruise automation for $581 million in 2016, in hopes of accelerating its development of autonomous vehicle technology. The automaker currently holds a 90 percent ownership stake. The company said it has agreements with other stakeholders to raise its stake to more than 97 percent and buy the remaining shares in Cruise LLC. “Contingent upon the repurchase of these shares and Cruise board approval, GM will work with the Cruise leadership team to restructure and refocus Cruise’s operations,” it stated. GM reported a $435 million loss from its majority-owned Cruise robotaxi division in the third quarter of 2024, down from the $791 million loss in the same period last year. The automaker previously announced plans for Cruise to generate $1 billion in annual revenue by 2025, but it scaled back its spending on the unit after one of its autonomous vehicles ran over a pedestrian who had been hit by another car in San Francisco on Oct. 2, 2023. The Cruise vehicle failed to detect a pedestrian was underneath it and dragged her over 20 feet while trying to pull over to the side of the road, the U.S. Attorney’s office of the Northern District of California stated in a press release last month. Prosecutors stated that Cruise filed a report with the National Highway Traffic Safety Administration describing the accident, but omitted reference to the secondary movement and dragging. Cruise eventually admitted to falsifying records and agreed to pay a $500,000 criminal fine. The incident led to Cruise’s license to operate its driverless fleet in California being suspended by regulators and triggered a leadership shake-up and layoffs that reduced its workforce by about a quarter.2 convicted in human smuggling case after Indian family froze to death on US-Canada border
Down 29%: Buy this cheap ASX stock for a 10% dividend yield
AI Is the Black MirrorNone
Netflix viewers are being urged to watch what they're dubbing one of the 'greatest films ever made', currently available on the platform ahead of an unexpected sequel set for release next year. The Accountant, first released in 2016, is now up for grabs on Netflix , with a sequel already in the pipeline for 2025. In this riveting movie, Ben Affleck plays Christian Wolff, an accountant on the autism spectrum. As a child, his father dismisses his mother's plea to send him to a neuroscience treatment center. Instead, leveraging his military background, Wolff's father trains him and his brother in martial arts and weaponry. As an adult, Christian becomes a forensic accountant who helps illegal organizations clean up their financial records and 'uncook' their books, according to the Daily Record. Netflix teases 'dark truths' of Jerry Springer Show exposed in upcoming documentary Netflix's new film is 'insane' true crime drama and fans can't stop talking about it When the FBI starts to suspect him, he takes on a state-of-the-art robotics company as a legitimate client. As Wolff unravels the truth about a discrepancy involving millions of dollars, the body count begins to rise. Affleck is backed in the film by Anna Kendrick, J. K. Simmons, and Jon Bernthal. Talks of a sequel first emerged in 2017, but as time passed, it seems many fans forgot about its existence. The possibility of a third installment was also hinted at, with filming finally kicking off in March of last year. The Batman actor's film has fans buzzing with approval as they urge newcomers to experience what many believe is one of his best roles. A fan gushed on Rotten Tomatoes, "Without a doubt Ben Affleck's best movie. Seen this numerous times and enjoy it each time. Stoked to here the sequel is in the works." Another added their two cents, "The Accountant is an insane thriller, which is sadly messy and has plenty of tone issues, but those are probably my only complaints of this. This is a great story with a great cast and some banging action, and the twists in this were great as well." Despite initially mixed reviews, audience sentiment has overwhelmingly turned positive, as another enthusiast noted: "I'm with the audience on this one, The Accountant is an excellent, fast moving movie. I could perhaps say its Ben Affleck's best performance to date. Well worth two hours of your time." Fans are also buzzing with anticipation for the upcoming The Accountant 2, already stamped with an R rating in America for its intense violence and explicit language. An excited fan posted on social media, "The accountant is still one of the best movies ever created. I can only hope accountant 2 is half as good." Echoing the excitement, someone else said, "I didn't know until now there will be Accountant 2, but I will watch it for sure. The 1st was a banger!"
Visa Inc. Cl A stock rises Friday, still underperforms marketAsia Distillates: Slew of deals emerge; gasoil cash premiums near 2-mth high
Generally speaking, if you are looking for a basic statistic that groups the good NBA teams and the bad teams together, it’s assist-to-turnover ratio. ADVERTISEMENT You certainly want as many assists as possible — that’s a sign of good offense. And you would like to limit giveaways that decrease your number of looks at the bucket while often feeding your opponent Grade A opportunities. The ratio balances out the equation for teams that may turn the ball over more than others simply because it moves the ball at such a high rate. The bad teams are the ones that turn the ball over often without the added benefit of creating easy shots when they do take care of the ball. That, currently, is the group that includes the Timberwolves. ADVERTISEMENT The Wolves have just 1.52 assists for every turnover, the sixth-worst mark in the NBA entering Saturday’s games. Of the nine NBA teams below 1.6, only the Wolves (8-7) and Clippers (10-7) have winning records, and the Clippers have been dominant defensively. Also in the bottom nine are the two-win Wizards, the three-win 76ers and Jazz and the four-win Pelicans. Since the 2020-21 season, nine teams have finished the season with an assist-to-turnover number below 1.6. Only one of those teams won more than 27 games — the 2022-23 Magic, who went 34-48. While the Wolves are still above .500 going into their game against the defending champion Celtics on Sunday in Boston, that’s with what has been the NBA’s fourth-easiest schedule to date, per ESPN. Timberwolves coach Chris Finch has cited the turnover issues in recent weeks when discussing his team’s struggles, though he’s noted the giveaway totals have dipped in recent games, Thursday’s loss to Toronto not withstanding. But Minnesota hasn’t committed fewer than 11 turnovers in a single game this season. Meanwhile, the Wolves have tallied fewer than 25 assists in more than half of their games. ADVERTISEMENT It all speaks to a disjointed offense. Finch has at times attributed that to missed shots that were good looks. But the Wolves are tied with Charlotte for the fifth-fewest potential assists this season, at 43.7 per game. The stats say Minnesota’s shot making is what has saved the Wolves’ offense this season. The Wolves have the NBA’s 10th-best offensive rating, averaging 1.14 points per possession. That’s with having the League’s fourth-best effective field goal percentage (56.3). The three teams above it in that category all average 1.2-plus points per possession. Those same squads also average more than 2.1 assists per turnover. It all fits the eye test for the Timberwolves. They have an offense that’s run on shot making off isolation basketball. So much of it is without the rhythm and movement Finch aspires for his teams to achieve. And, given that this Wolves unit doesn’t seem to be nearly as dominant defensively as it was one short season ago, until Minnesota can look more like a fluid offense, it will continue to look like a .500 team, or if not worse. ADVERTISEMENT ______________________________________________________ This story was written by one of our partner news agencies. Forum Communications Company uses content from agencies such as Reuters, Kaiser Health News, Tribune News Service and others to provide a wider range of news to our readers. Learn more about the news services FCC uses here .There were 14 seconds left to play when Illinois kicker David Olano lined up for the 58-yard, game-winning field goal. But his attempt to befriend the 16 mph winds at Rutgers’ home SHI Stadium failed as the football strayed left of the uprights. Not that it mattered. Rutgers coach Greg Schiano called a timeout to ice Olano before the ball was snapped, and Illinois coach Bret Bielema seized the chance to send his offense back on the field amid the unfriendly kicking conditions. On fourth-and-13, Illinois quarterback Luke Altmyer hit a 40-yard pass to wide receiver Pat Bryant for the score and 36-30 lead with four seconds remaining. Advertisement A quick game of hot potato by the Rutgers kick return team ended in a safety, and the 38-30 loss. No. 25 Illinois improves to 8-3, while Rutgers (6-5) drops its 41st consecutive loss to an AP top-25 ranked opponent. In each of the first 40 matchups, Rutgers lost by an average of 29.8 points. PAT BRYANT HOUSE CALL 🤯 He scores on fourth down with 4 second left for @Illinifootball !!️ #B1GFootball on Peacock 💻 pic.twitter.com/7VmxZztAqw — Big Ten Network (@BigTenNetwork) November 23, 2024 The Scarlet Knights haven’t beaten an AP top-25 team in 15 years; their last such victory was on Nov. 12, 2009, with a 31-0 crushing of then-No. 23 USF. Rutgers went 9-4 that year, ranking as high as No. 25. The Scarlet Knights were ranked in one season since, reaching No. 18 in 2012. The only other Power 4 team that hasn’t beaten an AP-ranked opponent in the 2020s is Nebraska, which has lost all such matchups since 2016. With the loss, the Scarlet Knights are no longer on track to produce their best season since 2014, when they went 8-5 overall. Since then, Rutgers posted one winning season: It came last year with a 7-6 overall record and Pinstripe Bowl victory. Required reading (Photo: Vincent Carchietta / Imagn Images)
The suspect, identified by police as Luigi Nicholas Mangione, had a gun believed to be the one used in Wednesday’s attack on Brian Thompson , as well as writings expressing anger at corporate America, police said. Here are some of the latest developments in the investigation: Where was the man captured? Mangione was taken into custody at around 9:15 a.m. after police received a tip that he was eating at a McDonald’s in Altoona, Pennsylvania, about 85 miles (137 kilometers) east of Pittsburgh, police said. Mangione was being held in Pennsylvania on gun charges and will eventually be extradited to New York to face charges in connection with Thompson’s death , said NYPD Chief of Detectives Joseph Kenny. What evidence did police find? In addition to a three-page, handwritten document that suggests he harbored “ill will toward corporate America,” Kenny said Mangione also had a ghost gun, a type of weapon that can be assembled at home and is difficult to trace. Officers questioned Mangione, who was acting suspiciously and carrying multiple fraudulent IDs, as well as a U.S. passport, New York Police Commissioner Jessica Tisch said at a news conference. Officers also found a sound suppressor, or silencer, “consistent with the weapon used in the murder,” the commissioner said. He had clothing and a mask similar to those worn by the shooter and a fraudulent New Jersey ID matching one the suspect used to check into a New York City hostel before the shooting, Tisch said. What do we know about Mangione? Kenny said Mangione was born and raised in Maryland, has ties to San Francisco and that his last known address is in Honolulu. Mangione, who was valedictorian of his Maryland prep school, earned undergraduate and graduate degrees in computer science in 2020 from the University of Pennsylvania, a university spokesman told The Associated Press on Monday. He learned to code in high school and helped start a club at Penn for people interested in gaming and game design, according to a 2018 story in Penn Today, a campus publication. His social media posts also suggest that he belonged to the fraternity Phi Kappa Psi. They also show him taking part in a 2019 program at Stanford University, and in photos with family and friends at the Jersey Shore and in Hawaii, San Diego, Puerto Rico, and other destinations. The Gilman School, from which Mangione graduated in 2016, is one of Baltimore’s elite prep schools. Some of the city’s wealthiest and most prominent people, including Orioles legend Cal Ripken Jr., have had children attend the school. Its alumni include sportswriter Frank Deford and former Arizona Gov. Fife Symington. In his valedictory speech, Luigi Mangione described his classmates’ “incredible courage to explore the unknown and try new things,” according to a post on the school website. He praised their collective inventiveness and pioneering mindset. Mangione took a software programming internship after high school at Maryland-based video game studio Firaxis, where he fixed bugs on the hit strategy game Civilization 6, according to a LinkedIn profile. Firaxis parent company Take-Two Interactive said Monday it would not comment on former employees. He more recently worked at the car-buying website TrueCar, according to the head of the Santa Monica, California-based company. “While we generally don’t comment on personnel matters, we confirm that Luigi Mangione has not been an employee of our company since 2023,” TrueCar CEO Jantoon Reigersman said by email. Mangione comes from a prominent Maryland family. His grandfather Nick Mangione, who died in 2008, was a successful real estate developer. One of his best-known projects was Turf Valley Resort, a sprawling luxury retreat and conference center outside Baltimore that he purchased in 1978. The father of 10 children, Nick Mangione prepared his five sons — including Luigi Mangione’s father, Louis Mangione — to help manage the family business, according to a 2003 Washington Post report. The Mangione family also purchased Hayfields Country Club north of Baltimore in 1986. On Monday, Baltimore County police officers blocked off an entrance to the property, which public records link to Luigi Mangione’s parents. Reporters and photographers gathered outside the entrance. Luigi Mangione is one of 37 grandchildren of Nick Mangione, according to the grandfather's obituary. Luigi Mangione's grandparents donated to charities through the Mangione Family Foundation, according to a statement from Loyola University commemorating Nick Mangione’s wife’s death in 2023. They donated to various causes ranging from Catholic organizations to colleges and the arts. One of Luigi Mangione’s cousins is Republican Maryland state legislator Nino Mangione, a spokesman for the lawmaker's office confirmed Monday. The shooting and a quick escape Police said the person who killed Thompson left a hostel on Manhattan's Upper West Side at 5:41 a.m. on Wednesday. Just 11 minutes later, he was seen on surveillance video walking back and forth in front of the New York Hilton Midtown, wearing a distinctive backpack. At 6:44 a.m., he shot Thompson at a side entrance to the hotel, fled on foot, then climbed aboard a bicycle and within four minutes had entered Central Park. Another security camera recorded the gunman leaving the park near the American Museum of Natural History at 6:56 a.m. still on the bicycle but without the backpack. After getting in a taxi, he headed north to a bus terminal near the George Washington Bridge, arriving at around 7:30 a.m. From there, the trail of video evidence runs cold. Police have not located video of the suspect exiting the building, leading them to believe he likely took a bus out of town. Police said they are still investigating the path the suspect took to Pennsylvania. “This just happened this morning," Kenny said. "We’ll be working, backtracking his steps from New York to Altoona, Pennsylvania,” Kenny said. Associated Press reporters Lea Skene in Baltimore, Matt O'Brien in Providence, Rhode Island, and Cedar Attanasio in New York contributed to this report.
Police arrested a 26-year-old man on Monday in the Manhattan killing of UnitedHealthcare’s CEO after they say a Pennsylvania McDonald's worker alerted authorities to a customer who resembled the suspected gunman. The suspect, identified by police as Luigi Nicholas Mangione, had a gun believed to be the one used in Wednesday’s attack on Brian Thompson , as well as writings expressing anger at corporate America, police said. Here are some of the latest developments in the investigation: Mangione was taken into custody at around 9:15 a.m. after police received a tip that he was eating at a McDonald’s in Altoona, Pennsylvania, about 85 miles (137 kilometers) east of Pittsburgh, police said. Mangione was being held in Pennsylvania on gun charges and will eventually be extradited to New York to face charges in connection with Thompson’s death , said NYPD Chief of Detectives Joseph Kenny. In addition to a three-page, handwritten document that suggests he harbored “ill will toward corporate America,” Kenny said Mangione also had a ghost gun, a type of weapon that can be assembled at home and is difficult to trace. Officers questioned Mangione, who was acting suspiciously and carrying multiple fraudulent IDs, as well as a U.S. passport, New York Police Commissioner Jessica Tisch said at a news conference. Officers also found a sound suppressor, or silencer, “consistent with the weapon used in the murder,” the commissioner said. He had clothing and a mask similar to those worn by the shooter and a fraudulent New Jersey ID matching one the suspect used to check into a New York City hostel before the shooting, Tisch said. Kenny said Mangione was born and raised in Maryland, has ties to San Francisco and that his last known address is in Honolulu. Mangione, who was valedictorian of his Maryland prep school, earned undergraduate and graduate degrees in computer science in 2020 from the University of Pennsylvania, a university spokesman told The Associated Press on Monday. He learned to code in high school and helped start a club at Penn for people interested in gaming and game design, according to a 2018 story in Penn Today, a campus publication. His social media posts also suggest that he belonged to the fraternity Phi Kappa Psi. They also show him taking part in a 2019 program at Stanford University, and in photos with family and friends at the Jersey Shore and in Hawaii, San Diego, Puerto Rico, and other destinations. The Gilman School, from which Mangione graduated in 2016, is one of Baltimore’s elite prep schools. Some of the city’s wealthiest and most prominent people, including Orioles legend Cal Ripken Jr., have had children attend the school. Its alumni include sportswriter Frank Deford and former Arizona Gov. Fife Symington. In his valedictory speech, Luigi Mangione described his classmates’ “incredible courage to explore the unknown and try new things,” according to a post on the school website. He praised their collective inventiveness and pioneering mindset. Mangione took a software programming internship after high school at Maryland-based video game studio Firaxis, where he fixed bugs on the hit strategy game Civilization 6, according to a LinkedIn profile. Firaxis parent company Take-Two Interactive said Monday it would not comment on former employees. He more recently worked at the car-buying website TrueCar, according to the head of the Santa Monica, California-based company. “While we generally don’t comment on personnel matters, we confirm that Luigi Mangione has not been an employee of our company since 2023,” TrueCar CEO Jantoon Reigersman said by email. Mangione comes from a prominent Maryland family. His grandfather Nick Mangione, who died in 2008, was a successful real estate developer. One of his best-known projects was Turf Valley Resort, a sprawling luxury retreat and conference center outside Baltimore that he purchased in 1978. The father of 10 children, Nick Mangione prepared his five sons — including Luigi Mangione’s father, Louis Mangione — to help manage the family business, according to a 2003 Washington Post report. The Mangione family also purchased Hayfields Country Club north of Baltimore in 1986. On Monday, Baltimore County police officers blocked off an entrance to the property, which public records link to Luigi Mangione’s parents. Reporters and photographers gathered outside the entrance. Luigi Mangione is one of 37 grandchildren of Nick Mangione, according to the grandfather's obituary. Luigi Mangione's grandparents donated to charities through the Mangione Family Foundation, according to a statement from Loyola University commemorating Nick Mangione’s wife’s death in 2023. They donated to various causes ranging from Catholic organizations to colleges and the arts. One of Luigi Mangione’s cousins is Republican Maryland state legislator Nino Mangione, a spokesman for the lawmaker's office confirmed Monday. Police said the person who killed Thompson left a hostel on Manhattan's Upper West Side at 5:41 a.m. on Wednesday. Just 11 minutes later, he was seen on surveillance video walking back and forth in front of the New York Hilton Midtown, wearing a distinctive backpack. At 6:44 a.m., he shot Thompson at a side entrance to the hotel, fled on foot, then climbed aboard a bicycle and within four minutes had entered Central Park. Another security camera recorded the gunman leaving the park near the American Museum of Natural History at 6:56 a.m. still on the bicycle but without the backpack. After getting in a taxi, he headed north to a bus terminal near the George Washington Bridge, arriving at around 7:30 a.m. From there, the trail of video evidence runs cold. Police have not located video of the suspect exiting the building, leading them to believe he likely took a bus out of town. Police said they are still investigating the path the suspect took to Pennsylvania. “This just happened this morning," Kenny said. "We’ll be working, backtracking his steps from New York to Altoona, Pennsylvania,” Kenny said. Associated Press reporters Lea Skene in Baltimore, Matt O'Brien in Providence, Rhode Island, and Cedar Attanasio in New York contributed to this report.None
Clinical and regulatory success in 2024 expected to drive value in 2025 CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "In fiscal year 2024 we drove tremendous progress in our pipeline. It was a transformative year, marked by our first FDA approval and significant clinical milestones. The approval of LYMPHIRTM and the positive Phase 3 results for Mino-Lok® underscore our commitment to developing innovative therapies. Our team successfully responded to FDA comments related to the biologics license application for LYMPHIR and ultimately gained FDA approval. Productive engagement with the FDA regarding the positive results of our Phase 3 Mino-Lok® trial and Phase 2 Halo-Lido trial clarified our next steps for both programs. We anticipate continued engagement with the agency in the coming year and look forward to their guidance. Additionally, we are exploring strategic partnerships and licensing opportunities to maximize the potential of our portfolio and bring these important therapies to market efficiently," stated Leonard Mazur , Chairman and CEO of Citius Pharma. "Looking ahead, our priorities for fiscal year 2025 include launching LYMPHIRTM through our majority-owned subsidiary, Citius Oncology, driving the clinical and regulatory strategies for Mino-Lok® and Halo-Lido, fortifying our financial position, and applying a disciplined approach to resource allocation. We expect to launch LYMPHIR in the first half of 2025 and distribute CTOR shares to Citius Pharma shareholders by the end of the year, pending favorable market conditions. Our goal remains to deliver value for patients, healthcare providers, and shareholders. With a clear vision and a strong team, we are well-positioned to execute on our mission of bringing innovative therapies to market," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Liquidity As of September 30, 2024 , the Company had $3.3 million in cash and cash equivalents. As of September 30, 2024 , the Company had 7,247,243 common shares outstanding, as adjusted for the 1-for-25 reverse stock split of the Company's common stock, effected on November 25, 2024 . During the year ended September 30, 2024 , the Company received net proceeds of $13.8 million from the issuance of equity. The Company expects to raise additional capital to support operations. Research and Development (R&D) Expenses R&D expenses were $11.9 million for the full year ended September 30, 2024 , compared to $14.8 million for the full year ended September 30, 2023 . The decrease in R&D expenses primarily reflects the completion of the Halo-Lido trial and completion of activities related to the regulatory resubmission for LYMPHIR, offset by shutdown costs associated with the end of the Phase 3 trial for Mino-Lok. We expect research and development expenses to decrease in fiscal year 2025 as we continue to focus on the commercialization of LYMPHIR through our majority-owned subsidiary, Citius Oncology and because we have completed the Phase 3 trial for Mino-Lok. General and Administrative (G&A) Expenses G&A expenses were $18.2 million for the full year ended September 30, 2024 , compared to $15.3 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-launch and market research activities associated with LYMPHIR. General and administrative expenses consist primarily of compensation costs, professional fees for legal, regulatory, accounting and corporate development services, and investor relations expenses. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $11.8 million as compared to $6.6 million for the prior year. The increase of $5.2 million is largely due to the grant of options under the Citius Oncology stock plan. Stock-based compensation expense under the Citius Oncology stock plan was $7.5 million during the year ended September 30, 2024 , compared to $2.0 million for the year ended September 30, 2023 , as the plan was initiated in July 2023 . For the years ended September 30, 2024 and 2023, stock-based compensation expense also includes $47,547 and $130,382 , respectively, for the NoveCite stock option plan. In fiscal years 2023 and 2024, we granted options to our new employees and additional options to other employees, our directors, and consultants. Net loss Net loss was $39.4 million , or ($5.97) per share for the year ended September 30, 2024 , compared to a net loss of $32.5 million , or ($5.57) per share for the year ended September 30, 2023 , as adjusted for the reverse stock split. The increase in net loss reflects an increase in operating expense of $5.3 million offset by a decrease of $1.6 million in other income. Operating expense increased due to increases in stock-based compensation and general and administrative expenses, which were offset by decreased research and development expense. About Citius Pharmaceuticals, Inc. Citius Pharma is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024 , the FDA approved LYMPHIRTM, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Citius Pharma's late-stage pipeline also includes Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 Trial. Citius Pharma is actively engaged with the FDA to outline next steps for both programs. For more information, please visit www.citiuspharma.com . Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Pharma. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Pharma are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR through our majority-owned subisity and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; risks related to research using our assets but conducted by third parties; risks relating to the results of research and development activities, including those from our existing and any new pipeline assets; our ability to maintain compliance with Nasdaq's continued listing standards; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; the early stage of products under development; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Pharma's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 ASSETS Current Assets: Cash and cash equivalents $ 3,251,880 $ 26,480,928 Inventory 8,268,766 — Prepaid expenses 2,700,000 7,889,506 Total Current Assets 14,220,646 34,370,434 Property and equipment, net — 1,432 Operating lease right-of-use asset, net 246,247 454,426 Other Assets: Deposits 38,062 38,062 In-process research and development 92,800,000 59,400,000 Goodwill 9,346,796 9,346,796 Total Other Assets 102,184,858 68,784,858 Total Assets $ 116,651,751 $ 103,611,150 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 4,927,211 $ 2,927,334 License payable 28,400,000 — Accrued expenses 17,027 476,300 Accrued compensation 2,229,018 2,156,983 Operating lease liability 241,547 218,380 Total Current Liabilities 35,814,803 5,778,997 Deferred tax liability 6,713,800 6,137,800 Operating lease liability – non current 21,318 262,865 Total Liabilities 42,549,921 12,179,662 Commitments and Contingencies Stockholders' Equity: Preferred stock - $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding — — Common stock - $0.001 par value; 16,000,000 shares authorized; 7,247,243 and 6,354,371 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,247 6,354 Additional paid-in capital 271,440,421 253,056,133 Accumulated deficit (201,370,218) (162,231,379) Total Citius Pharmaceuticals, Inc. Stockholders' Equity 70,077,450 90,831,108 Non-controlling interest 4,024,380 600,380 Total Equity 74,101,830 91,431,488 Total Liabilities and Equity $ 116,651,751 $ 103,611,150 Reflects a 1-for-25 reverse stock split effective November 25, 2024. CITIUS PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 11,906,601 14,819,729 General and administrative 18,249,402 15,295,584 Stock-based compensation – general and administrative 11,839,678 6,616,705 Total Operating Expenses 41,995,681 36,732,018 Operating Loss (41,995,681) (36,732,018) Other Income: Interest income, net 758,000 1,179,417 Gain on sale of New Jersey net operating losses 2,387,842 3,585,689 Total Other Income Net 3,145,842 4,765,106 Loss before Income Taxes (38,849,839) (31,966,912) Income tax expense 576,000 576,000 Net Loss (39,425,839) (32,542,912) Net loss attributable to non-controlling interest 287,000 - Deemed dividend on warrant extension (1,047,312) (1,151,208) Net Loss Applicable to Common Stockholders $ (40,186,151) (33,694,120) Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted $ (5.97) (5.57) Weighted Average Common Shares Outstanding
None
Gabbard's bipartisan congressional connections could be crucial to confirmationPolice arrested a 26-year-old man on Monday in the Manhattan killing of UnitedHealthcare’s CEO after they say a Pennsylvania McDonald's worker alerted authorities to a customer who resembled the suspected gunman. The suspect, identified by police as Luigi Nicholas Mangione, had a gun believed to be the one used in Wednesday’s attack on Brian Thompson , as well as writings expressing anger at corporate America, police said. Here are some of the latest developments in the investigation: Mangione was taken into custody at around 9:15 a.m. after police received a tip that he was eating at a McDonald’s in Altoona, Pennsylvania, about 85 miles (137 kilometers) east of Pittsburgh, police said. Mangione was being held in Pennsylvania on gun charges and will eventually be extradited to New York to face charges in connection with Thompson’s death , said NYPD Chief of Detectives Joseph Kenny. In addition to a three-page, handwritten document that suggests he harbored “ill will toward corporate America,” Kenny said Mangione also had a ghost gun, a type of weapon that can be assembled at home and is difficult to trace. Officers questioned Mangione, who was acting suspiciously and carrying multiple fraudulent IDs, as well as a U.S. passport, New York Police Commissioner Jessica Tisch said at a news conference. Officers also found a sound suppressor, or silencer, “consistent with the weapon used in the murder,” the commissioner said. He had clothing and a mask similar to those worn by the shooter and a fraudulent New Jersey ID matching one the suspect used to check into a New York City hostel before the shooting, Tisch said. Kenny said Mangione was born and raised in Maryland, has ties to San Francisco and that his last known address is in Honolulu. Mangione, who was valedictorian of his Maryland prep school, earned undergraduate and graduate degrees in computer science in 2020 from the University of Pennsylvania, a university spokesman told The Associated Press on Monday. He learned to code in high school and helped start a club at Penn for people interested in gaming and game design, according to a 2018 story in Penn Today, a campus publication. His social media posts also suggest that he belonged to the fraternity Phi Kappa Psi. They also show him taking part in a 2019 program at Stanford University, and in photos with family and friends at the Jersey Shore and in Hawaii, San Diego, Puerto Rico, and other destinations. The Gilman School, from which Mangione graduated in 2016, is one of Baltimore’s elite prep schools. Some of the city’s wealthiest and most prominent people, including Orioles legend Cal Ripken Jr., have had children attend the school. Its alumni include sportswriter Frank Deford and former Arizona Gov. Fife Symington. In his valedictory speech, Luigi Mangione described his classmates’ “incredible courage to explore the unknown and try new things,” according to a post on the school website. He praised their collective inventiveness and pioneering mindset. Mangione took a software programming internship after high school at Maryland-based video game studio Firaxis, where he fixed bugs on the hit strategy game Civilization 6, according to a LinkedIn profile. Firaxis parent company Take-Two Interactive said Monday it would not comment on former employees. He more recently worked at the car-buying website TrueCar, according to the head of the Santa Monica, California-based company. “While we generally don’t comment on personnel matters, we confirm that Luigi Mangione has not been an employee of our company since 2023,” TrueCar CEO Jantoon Reigersman said by email. Mangione comes from a prominent Maryland family. His grandfather Nick Mangione, who died in 2008, was a successful real estate developer. One of his best-known projects was Turf Valley Resort, a sprawling luxury retreat and conference center outside Baltimore that he purchased in 1978. The father of 10 children, Nick Mangione prepared his five sons — including Luigi Mangione’s father, Louis Mangione — to help manage the family business, according to a 2003 Washington Post report. The Mangione family also purchased Hayfields Country Club north of Baltimore in 1986. On Monday, Baltimore County police officers blocked off an entrance to the property, which public records link to Luigi Mangione’s parents. Reporters and photographers gathered outside the entrance. Luigi Mangione is one of 37 grandchildren of Nick Mangione, according to the grandfather's obituary. Luigi Mangione's grandparents donated to charities through the Mangione Family Foundation, according to a statement from Loyola University commemorating Nick Mangione’s wife’s death in 2023. They donated to various causes ranging from Catholic organizations to colleges and the arts. One of Luigi Mangione’s cousins is Republican Maryland state legislator Nino Mangione, a spokesman for the lawmaker's office confirmed Monday. Police said the person who killed Thompson left a hostel on Manhattan's Upper West Side at 5:41 a.m. on Wednesday. Just 11 minutes later, he was seen on surveillance video walking back and forth in front of the New York Hilton Midtown, wearing a distinctive backpack. At 6:44 a.m., he shot Thompson at a side entrance to the hotel, fled on foot, then climbed aboard a bicycle and within four minutes had entered Central Park. Another security camera recorded the gunman leaving the park near the American Museum of Natural History at 6:56 a.m. still on the bicycle but without the backpack. After getting in a taxi, he headed north to a bus terminal near the George Washington Bridge, arriving at around 7:30 a.m. From there, the trail of video evidence runs cold. Police have not located video of the suspect exiting the building, leading them to believe he likely took a bus out of town. Police said they are still investigating the path the suspect took to Pennsylvania. “This just happened this morning," Kenny said. "We’ll be working, backtracking his steps from New York to Altoona, Pennsylvania,” Kenny said. Associated Press reporters Lea Skene in Baltimore, Matt O'Brien in Providence, Rhode Island, and Cedar Attanasio in New York contributed to this report. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Get the latest local business news delivered FREE to your inbox weekly.
Chief 'disappointed' to see clean water used as a political tactic by ConservativesPerella Weinberg chairman Peter A. Weinberg sells $3.58m in stock